Clinical Trials for Malignant Solid Tumor

Find clinical trials for malignant solid tumor. Discover research opportunities and treatment options in your area.

11 Active Trials Found

Showing 11 trials on this page

Page 1 of 1

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

NCT ID: NCT06824363

This clinical trial is designed to test a new treatment approach for patients with specific types of stomach and esophageal cancers that have a mutation in a gene called ARID1A. The study aims to s...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Orange, California, United States

Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

NCT ID: NCT06735144

This clinical trial is studying a new treatment called FH-006 for patients with advanced malignant solid tumors, which are a type of cancer that forms in solid organs like the lungs, breast, or col...

Recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

NCT ID: NCT05629689

This clinical trial is looking at two new substances, GEH200520 and GEH200521, which are used in a type of imaging called PET scans. These scans help doctors see what's happening inside the body, e...

Recruiting

Phase: PHASE1 Type: interventional Locations: Groningen, , Netherlands

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

NCT ID: NCT06171750

This clinical trial is studying a new treatment called ANK-101 for patients with advanced solid tumors, which are cancers that form lumps or masses in different parts of the body. The trial is in i...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Pittsburgh, Pennsylvania, United States +2 more

A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors

NCT ID: NCT05859464

This clinical trial is studying a new treatment called ZL-1218 for adults with advanced solid tumors, which are types of cancers that form solid masses, like breast or lung cancer. The trial aims t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hackensack, New Jersey, United States, New York, New York, United States +13 more

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

NCT ID: NCT04145622

This clinical trial is studying a new drug called ifinatamab deruxtecan (I-DXd) for patients with advanced solid tumors that have not responded to other treatments. The trial has two parts: the fir...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Detroit, Michigan, United States +24 more

A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/characteristics in Advanced / Metastatic Tumors.

NCT ID: NCT04116541

This clinical trial is examining the effectiveness and safety of new anti-cancer treatments that are tailored to specific changes found in tumors of patients with advanced or metastatic solid tumor...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nice, , France, Villejuif, , France +8 more

Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors

NCT ID: NCT05141474

This clinical trial is studying a new treatment approach for patients with advanced epithelial tumors and solid tumors that have not responded well to standard immunotherapies. The treatment involv...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Barcelona, , Spain

CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)

NCT ID: NCT04151342

The CARMA study is a clinical trial focusing on Canadian patients with cancer who have unusual changes in their tumor DNA. These changes can affect how the cancer behaves and how it responds to spe...

Recruiting

Type: observational Locations: Montreal, Quebec, Canada, Toronto, Ontario, Canada +28 more

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

NCT ID: NCT05727839

This clinical trial is looking at a new treatment called JCXH-211, which is given as an injection directly into tumors. The goal of the trial is to see how safe the treatment is, how well it works,...

Recruiting

Phase: PHASE1 Type: interventional Locations: Guangdong, Guangzhou, China

A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT04632108

This clinical trial is studying a new treatment called ASKB589 for patients with advanced solid tumors, particularly those with gastric cancer, gastroesophageal junction adenocarcinoma, or pancreat...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China, Linyi, Shandong, China +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions